Clinical Trials Logo
  1. Home
  2. Helicobacter Pylori Eradication
  3. NCT02873065

Efficacy and Safety of 1-week Triple Therapy With Ilaprazole for the Eradication of Helicobacter Pylori

Helicobacter Pylori Eradication Clinical Trial

Clinical Trial Summary

This study compared efficacy and safety of Ilaprazole based triple regimen therapy including Ilaprazole 5mg, Clarithromycin 500mg and Amoxicillin Cap(Amoxicillin) 1000mg BID on the first line eradication treatment of H.pylori

Clinical Trial Description

Participants are defined as persons who have endoscopically confirmed on gastric or duodenal ulcer(including scar stage) ,gastritis and dyspepsia confirmed to be H.pylori positive patients in the biopsy and UBT test. For 7 days, Participants treated as Esoprazole based triple regimen therapy therapy including Esoprazole 20mg，Clarithromycin 500mg and Amoxicillin Cap(Amoxicillin) 1000mg BID. After treatment, The healing rate was evaluated in the UBT test and Biopsy at 49±5days from the first day dosing ;

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02873065
Study type Interventional
Source Livzon Pharmaceutical Group Inc.
Contact
Status Completed
Phase Phase 4
Start date September 2014
Completion date June 2015
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT06349486 - Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy, Vonoprazan-amoxicillin Dual Therapy and Proton Pump Inhibitor-based Standard Triple Therapy for Hp Eradication N/A
Completed NCT03924375 - Serum Pepsinogen After H. Pylori Eradication
Recruiting NCT04034641 - Effect of Probiotics on Helicobacter Pylori Eradication Phase 4
Completed NCT04850209 - The Impact of WeChat Group Patient Education on the Eradication Rate of Helicobacter Pylori N/A
Not yet recruiting NCT04558502 - Effectiveness of Minocycline-Containing Bismuth Quadruple Therapy for Helicobacter Pylori Eradication Phase 4
Completed NCT06101420 - Potassium Copetitive Acid Blockers Efficacy in H.Pylori Eradication Phase 3
Recruiting NCT06088316 - Efficacy of Amoxicillin-Esomeprazole HDDT Compared to Levofloxacin Triple Therapy for H. Pylori Eradication: A RCT Phase 4
Recruiting NCT05850117 - Efficacies of Tetracycline-levofloxacin, Standard Bismuth, Amoxicillin-levofloxacin Quadruple Therapy for H.p N/A
Recruiting NCT05191888 - 14-day PCAB-based High-dose Dual Therapy and14-day PCAB-based Triple Therapy vs 14-day PPI-based Reverse Hybrid Therapy Phase 4
Recruiting NCT05870397 - Optimal Recheck Time for Helicobacter Pylori Eradication: A Prospective Randomized Trial N/A